Home Company Modular Microencapsulation Units Publications Applications Gallery Upcoming Events Links Contact

See the overview of the scientific patents where the Nisco’s encapsulation units have been applied.

Unit type Application Article name Autor/Organisation Published
VAR D / Gen II Thermal The method of encapsulation is characterized by the step of counter-current, diffusional exchange across the membrane of a capsule-shell. During the exchange, a primary core is replaced by a liquid that may comprise an active agent. Optimisation of the active agent relaese caracteristics. Core-shell capsules and methods for encapsulation of reactive ingredients by diffusional exchange through spherical capsule membranes INVENTOR(S): MEINERS JEAN ANTOINE [CH]; ZEGELS ALEXANDRE [CH]  /  APLICANT(S): MEINERS SARL LAB [CH] EP2684600 (A1) ― 2014-01-15 (WO2014009370 (A2) ― 2014-01-16); (WO2014009370 (A3) ― 2014-06-12)
VAR D The present invention relates to a biocompatible vascularising and cicatrizing drug-delivery matrix that stimulates the vascularisation, cicatrisation and the regeneration of tissues and organs. Bicompatible vascularising and cicatrizing drug-delivery matrix INVENTOR(S): MARTIN DEL VALLE EVA MARIA [ES]; GALAN SERRANO MIGUEL ANGEL [ES]; PEREZ HERRERO EDGAR [ES]; VARELA SIMO GONZALO [ES]; ARANDA ALCAIDE JOSE LUIS [ES] /  APLICANT(S): UNIV SALAMANCA [ES]  + EP2359877 (A1) ― 2011-08-24
VAR D The present application relates to particles, compositions comprising such particles, and processes for making and using such particles and compositions.  DELIVERY PARTICLE INVENTOR(S): SMETS JOHAN [BE]; FERNANDEZ PRIETO SUSANA [ES]  + / APLICANT(S): The Procter and Gamble Company, US US2010251485 (A1) ― 2010-10-07; ;  (JP2012522072 (A) ― 2012-09-20);    
VAR D The present application relates to particles, compositions comprising such particles, and processes for making and using such particles and compositions.  COMPOSITION COMPRISING DELIVERY PARTICLES INVENTOR(S): SMETS JOHAN [BE]; FERNANDEZ PRIETO SUSANA [ES]  + / APLICANT(S): The Procter and Gamble Company, US CA2754009 (A1) ― 2010-10-07; (WO2010114753 (A1) ― 2010-10-07); (MX2011010364 (A) ― 2011-10-12); (AU2010232858 (A1) ― 2011-10-27); (EP2414497 (A1) ― 2012-02-08); (CN102361965 (A) ― 2012-02-22); 
VAR D and J30 Methods of screening of biomolecules and biological systems / Porous, gel-like particle for incubation of candidates and sensors within close vicinity to each other. SUSPENSION ARRAYS FOR SPECIES-SPECIES INTERACTION STUDIES INVENTOR(S): PANKE SVEN [CH]; PELLAUX RENE [CH]; HELD MARTIN [CH]; MEYER ANDREAS [CH]  + / APLICANT(S): ETH ZUERICH [CH]; PANKE SVEN [CH]; PELLAUX RENE [CH]; HELD MARTIN [CH]; MEYER ANDREAS [CH]  + , Switzerland WO2009132820 (A1) ― 2009-11-05 
VAR D A particle with a diameter of at most about 3,000 microns has an internal pressure of at least about 1.1 atmospheres at a temperature of less than about 25 DEG C. PARTICLES / PARTICLES WITH HIGH INTERNAL PRESSURE FOR TISSUE ABLATION INVENTOR(S): ANDERSON STEVEN M [US]; LANPHERE JANEL [US] / APLICANT(S): BOSTON SCIENT LTD [BB] US2006199009 (A1) ― 2006-09-07; (CA2598680 (A1) ― 2006-09-08); (WO2006093969 (A2) ― 2006-09-08); (EP1853314 (A2) ― 2007-11-14); (WO2006093969 (A3) ― 2008-04-24);  ( US7858183 (B2) ― 2010-12-28 ); 
VAR D Methods of preparation of particles with different form. PARTICLES INVENTOR(S): BUISER MARCIA [US]; MCKENNA ERIN [US]; CASEY THOMAS V III [US]; LANPHERE JANEL [US]; DICARLO PAUL [US] / APLICANT(S): BOSTON SCIENT LTD [BB] US2006199010 (A1) ― 2006-09-07; CA2598559 (A1) ― 2006-09-08; (WO2006093972 (A2) ― 2006-09-08); (WO2006093972 (A3) ― 2007-11-08); (EP1874449 (A2) ― 2008-01-09);  (US7727555 (B2) ― 2010-06-01)
VAR D Embolization, as well as related particles and methods, are described. Embolization   INVENTOR(S): LANPHERE JANEL [US]; BUISER MARCIA [US]; CASEY II THOMAS V [US] / APLICANT(S): BOSTON SCIENT SCIMED INC [US] US2005263916 (A1) ― 2005-12-01; ( WO2005118128 (A1) ― 2005-12-15); (CA2567920 (A1) ― 2005-12-15);  WO2005118128 (A8) ― 2006-02-09); (EP1753530 (A1) ― 2007-02-21); (US7311861 (B2) ― 2007-12-25); (JP2008502463 (A) ― 2008-01-31); (US2008041715 (A1) ― 2008-02-21); ( US7666333 (B2) ― 2010-02-23); (US2010109178 (A1) ― 2010-05-06); (US7964123 (B2) ― 2011-06-21); 
VAR D A composition comprising a substantially spherical polymer particle having a diameter of about 1200 microns or less. The agents can be radioactive specie s. The agents can be therapeutic agents. The agents can be in and/or on the particles. AGENT DELIVERY PARTICLE INVENTOR(S): DIMATTEO KRISTIAN [US]; CASEY THOMAS V II [US]; RIOUX ROBERT F [US]; LANPHERE JANEL [US]; KEENAN STEVE [US] / APLICANT(S): BOSTON SCIENT LTD [BB] / APLICANT(S): BOSTON SCIENT LTD [BB]  CA2496611 (A1) ― 2004-03-11; WO2004019999 (A2) ― 2004-03-11); (AU2003268313 (A1) ― 2004-03-19); (US2004076582 (A1) ― 2004-04-22); (WO2004019999 (A3) ― 2004-04-29); (EP1531873 (A2) ― 2005-05-25); (NZ538403 (A) ― 2006-11-30); AU2003268313 (B2) ― 2008-08-21); (CA2496611 (C) ― 2011-04-26);        EP1531873 (B1) ― 2011-09-21)
VAR D Embolic particles, as well as their methods of use and manufacture, are described. EMBOLIZATION INVENTOR(S): CASEY THOMAS V II [US]; ST PIERRE ERNEST J [US]; KAPOGLIS GREG [US]; LANPHERE JANEL [US] / APLICANT(S): BOSTON SCIENT LTD [BB] CA2494959 (A1) ― 2004-02-19; (WO2004014446 (A1) ― 2004-02-19); (AU2003259723 (A1) ― 2004-02-25); (WO2004014446 (A9) ― 2004-04-15); (EP1534351 (A1) ― 2005-06-01); (JP2005535752 (A) ― 2005-11-24); (EP1534351 (B1) ― 2006-10-04); (DE60308880 (T2) ― 2007-05-24); (AU2003259723 (B2) ― 2009-04-23); (CA2494959 (C) ― 2011-09-13)         
VAR D Embolic particles, as well as their methods of use and manufacture, are described. Embolization INVENTOR(S): LANPHERE JANEL [US]; ST PIERRE ERNEST J [US]; KAPOGLIS GREG [US]; CASEY THOMAS V [US] + / APLICANT(S): LANPHERE JANEL, ; ST. PIERRE ERNEST J, ; KAPOGLIS GREG, ; CASEY THOMAS V, ; BOSTON SCIENTIFIC SCIMED, INC  US2004096662 (A1) ― 2004-05-20; (US7449236 (B2) ― 2008-11-11)
VAR D Embolic polymer particles are described. For example, the particles include pores such that the predominant size of pores near the center of particles is greater than the predominant size of pores adjacent to periphery of the particle. EMBOLIZATION INVENTOR(S): BUISER MARCIA [US]; BELLISARIO MARC [US]; KNAPP DAVID [US]; MANGIN STEPHAN [US]; LANPHERE JANEL [US] / APLICANT(S): BOSTON SCIENT LTD [BB]  WO03084582 (A1) ― 2003-10-16; (CA2480579 (A1) ― 2003-10-16); (AU2003230746 (A1) ― 2003-10-20); (EP1490120 (A1) ― 2004-12-29); (EP1490120 (B1) ― 2009-11-11)
VAR D A particle includes a ferromagnetic material, a radiopaque material, and/or an MRI-visible material. EMBOLIZATION INVENTOR(S): RIOUX ROBERT F; CASEY THOMAS V II; LANPHERE JANEL + / APLICANT(S): SCIMED LIFE SYSTEMS INC [US]  + WO2004020011 (A1) ― 2004-03-11; (CA2496612 (A1) ― 2004-03-11) (AU2003270050 (A1) ― 2004-03-19); (EP1531874 (A1) ― 2005-05-25); (EP1531874 (B1) ― 2009-04-22);  (US2013079767 (A1) ― 2013-03-28);
VAR D A drug delivery particle including a reservoir region having primarily large pores and a metering region. The particle can be highly spherical. Drug delivery particle INVENTOR(S): LANPHERE JANEL [US]; MCKENNA ERIN [US]; NAIMARK WENDY [US]; BUISER MARCIA [US]; MANGIN STEPHAN [US] + / APLICANT(S): LANPHERE JANEL, ; MCKENNA ERIN, ; NAIMARK WENDY, ; BUISER MARCIA, ; MANGIN STEPHAN, ; BOSTON SCIENTIFIC SCIMED, INC US2003185895 (A1) ― 2003-10-02; (ZA200502434 (A) ― 2005-10-10);   JP2005537070 (A) ― 2005-12-08); (US7462366 (B2) ― 2008-12-09); (US2009035352 (A1) ― 2009-02-05); (US7951402 (B2) ― 2011-05-31); 
VAR D Manufacuring a drug delivery particle and delivering a therapeutic agent to a patient DRUG DELIVERY PARTICLE INVENTOR(S): LANPHERE JANEL [US]; MCKENNA ERIN [US]; NAIMARK WENDY [US]; BUISER MARCIA [US]; MANGIN STEPHAN [US]  + / APLICANT(S): SCIMED LIFE SYSTEMS INC [US]; LANPHERE JANEL [US]; MCKENNA ERIN [US]; NAIMARK WENDY [US]; BUISER MARCIA [US]; MANGIN STEPHAN [US]  + WO03082360 (A1) ― 2003-10-09; (CA2480632 (A1) ― 2003-10-09); (AU2003258167 (A1) ― 2003-10-13); (EP1490121 (A1) ― 2004-12-29);   (JP2005533008 (A) ― 2005-11-04); (EP1490121 (B1) ― 2009-11-04); (JP4820057 (B2) ― 2011-11-24)
VAR D A method of treating tissue includes placing substantially spherical polymer particles in the tissue.  TISSUE TREATMENT INVENTOR(S): BOURNE GEORGE [US]; BUISIER MARCIA [US]; CASEY THOMAS V II [US]; KEENAN STEVE [US]; LANPHERE JANEL [US]; LI JIANMIN [US]; MCKENNA ERIN [US]; MINASIAN ZAROUHI [US]; RAO DOREEN [US] / APLICANT(S): SCIMED LIFE SYSTEMS INC [US]; BOURNE GEORGE [US]; BUISIER MARCIA [US]; CASEY THOMAS V II [US]; KEENAN STEVE [US]; LANPHERE JANEL [US]; LI JIANMIN [US]; MCKENNA ERIN [US]; MINASIAN ZAROUHI [US]; RAO DOREEN [US]  WO03082359 (A1) ― 2003-10-09; (CA2480630 (A1) ― 2003-10-09);  (AU2003223372 (A1) ― 2003-10-13); (EP1490119 (A1) ― 2004-12-29); (JP2005521476 (A) ― 2005-07-21); (JP4364649 (B2) ― 2009-11-18); 
VAR D A method of treating tissue includes placing substantially spherical polymer particles in the tissue.  Tissue treatment INVENTOR(S): BOURNE GEORGE [US]; BUISER MARCIA [US]; CASEY THOMAS V [US]; KEENAN STEVE [US]; LANPHERE JANEL [US]; LI JIANMIN [US]; MCKENNA ERIN [US]; MINASIAN ZAROUHI [US]; RAO DOREEN [US] / APLICANT(S): BOURNE GEORGE, ; BUISER MARCIA, ; CASEY THOMAS V, ; KEENAN STEVE, ; LANPHERE JANEL, ; LI JIANMIN, ; MCKENNA ERIN, ; MINASIAN ZAROUHI, ; RAO DOREEN, ; SCIMED LIFE SYSTEMS, INC  US2003233150 (A1) ― 2003-12-18; (US7131997 (B2) ― 2006-11-07); (US2007059375 (A1) ― 2007-03-15); (US7611542 (B2) ― 2009-11-03)

 

Back

© 2009 - 2015 Nisco Engineering AG · Contact